Hycult Biotech
Complement research in drug development
Bridging complement biology from discovery to therapy
The development of complement-targeting therapeutics requires a clear and reliable path from discovery to preclinical decision-making. A key challenge is translating results from animal studies into data that are robust, reproducible, and truly relevant for human drug development.
Generate translationally relevant complement data
Hycult Biotech offers validated complement assays that enable confident assessment of complement activation and inhibition throughout preclinical development. By generating high-quality data early, these tools support optimized study design and informed go/no-go decisions.
Improve efficiency in preclinical complement research
Well-designed ex vivo complement activation assays, including serum-based approaches, help focus in vivo studies on where they add the most value while minimizing repetitive experimentation. This results in more efficient preclinical programs, stronger human relevance, and improved outcomes driven by better data.
Assays for mouse and rat enabling confident preclinical decisions
Our functional pathway assays and sC5b-9 measurements are designed to perform reliably across species and development stages. Product selection includes scientific alignment to ensure assays match the intended application, supporting reliable translation from preclinical research toward clinical development.
Expert Guidance in Assay Selection and Study Design
Hycult Biotech combines in-depth knowledge of the complement system with extensive expertise in assay development and validation. We actively support researchers in selecting the most appropriate assays for their specific research questions, ensuring that experimental strategies are scientifically sound, efficient, and translatable. By aligning assay choice with study objectives and regulatory expectations, Hycult helps maximize data quality while minimizing unnecessary in vivo experimentation.
Other interesting posts
